Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 130 peer-reviewed journal articles Updated
Hematology

Understanding Beta-Thalassemia Major: A Guide for Parents and Patients

At a Glance

Beta-thalassemia major (Cooley's Anemia) is an inherited blood disorder that prevents the body from making enough healthy hemoglobin. Treatment requires regular blood transfusions and iron chelation therapy, though curative stem cell and gene therapies are now available.

Receiving a diagnosis of Beta-thalassemia major (also known as Cooley’s Anemia) for your child can feel overwhelming [1][2]. It is natural to feel a sense of shock or fear, but it is important to know that you are not alone, and this diagnosis is not your fault [3]. Beta-thalassemia major is an inherited genetic condition; it is not caused by anything you did or didn’t do during pregnancy [3][4].

The path forward is well-defined. With modern, optimal care, life expectancy is steadily approaching normal, allowing patients to pursue careers and start families of their own [5][6].

This guide is designed to empower you with the knowledge you need to advocate for your child’s health.

Navigating This Guide

01

The Biology and Genetics of Beta-Thalassemia Major

Learn about the biology and genetics of Beta-thalassemia major. Understand HBB gene mutations, the beta-zero vs. beta-plus difference, and how it is inherited.

02

Signs, Symptoms, and Diagnosing Beta-Thalassemia Major

Learn the early signs of beta-thalassemia major in infants and understand the diagnostic process, including CBC, hemoglobin tests, and genetic testing.

03

The Standard of Care: Blood Transfusions and Iron Chelation Therapy

Learn about the standard of care for beta-thalassemia major (TDT). Understand the timeline, goals, and medications for blood transfusions and iron chelation.

04

Curative Options: Stem Cell Transplants and Gene Therapy

Learn about curative options for beta-thalassemia major. Understand the differences between stem cell transplants (HSCT) and FDA-approved gene therapies.

05

Long-Term Monitoring: Protecting the Organs and Managing Iron Overload

Learn how to monitor and manage iron overload in beta-thalassemia major. Understand cardiac T2* MRI, liver scans, endocrine tests, and bone health tracking.

What is Beta-Thalassemia Major?

In simple terms, your child’s body has difficulty making enough hemoglobin, the protein in red blood cells that carries oxygen to the rest of the body [1]. Specifically, their body does not produce enough beta-globin chains, which are essential building blocks of normal hemoglobin [1].

Because their body cannot make enough healthy red blood cells on its own, they develop severe anemia (a low red blood cell count) [2]. This is why they will need regular blood transfusions—to provide the healthy red blood cells their body needs to grow and thrive [2][1].

Because your child will receive frequent blood transfusions, their body will naturally accumulate too much iron [2][1]. The body has no natural way to get rid of this extra iron, and if left untreated, it can build up in vital organs like the heart and liver [2][7]. To prevent this, your child will eventually start iron chelation therapy [8]. This involves taking medication that binds to the extra iron and helps the body remove it [8][9].

Correcting Common Misunderstandings

  • It is not contagious: You cannot “catch” thalassemia. It is strictly a genetic condition passed from parents to children [3].
  • It is not “just” anemia: Unlike iron-deficiency anemia, which can be treated with iron supplements, Beta-thalassemia major requires specialized care from a hematologist (a doctor who specializes in blood) [2]. In fact, giving over-the-counter iron supplements to a child with thalassemia can be dangerous [2].
  • Activity is possible: While children may feel tired if their hemoglobin levels are low, most children with well-managed thalassemia can participate in school, sports, and normal childhood activities [10][11].

Common questions in this guide

What causes Beta-thalassemia major?
Beta-thalassemia major is an inherited genetic condition caused by mutations in the HBB gene. It is passed down from parents to children and affects the body's ability to produce healthy hemoglobin.
Is Beta-thalassemia major contagious?
No, you cannot catch Beta-thalassemia major from someone else. It is strictly a genetic blood disorder that a person is born with.
Can I give my child with thalassemia over-the-counter iron supplements?
No, you should never give over-the-counter iron supplements to a child with Beta-thalassemia major. Because they receive frequent blood transfusions, they already have excess iron in their bodies, and additional iron can be dangerous.
What are the main treatments for Beta-thalassemia major?
The standard of care involves regular blood transfusions to treat severe anemia, combined with iron chelation therapy to remove excess iron from the body. Curative options like stem cell transplants and gene therapies are also available for eligible patients.
Can children with Beta-thalassemia major play sports and go to school?
Yes. While they may experience fatigue if their hemoglobin levels are low, with proper medical management, most children with Beta-thalassemia major can attend school, participate in sports, and enjoy normal childhood activities.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my child's specific genetic mutation profile (e.g., β0/β0 or β0/β+), and how does it affect their treatment plan?
  2. 2.Is my child a candidate for hematopoietic stem cell transplantation (HSCT) or gene therapy?
  3. 3.What is our target range for my child’s hemoglobin levels and ferritin levels?
  4. 4.How can we minimize the risk of 'alloimmunization' during my child's first few transfusions?
  5. 5.Can you help me understand the schedule for monitoring my child’s heart and liver iron levels as they grow?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

What Is the Life Expectancy for Beta-Thalassemia Major?

References

References (11)
  1. 1

    Effect of breastfeeding versus infant formula on iron status of infants with beta thalassemia major.

    El Safy UR, Fathy MM, Hassan TH, et al.

    International breastfeeding journal 2016; (12()):18 doi:10.1186/s13006-017-0111-3.

    PMID: 28428807
  2. 2

    Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients.

    Russo V, Rago A, Papa AA, Nigro G

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2016; (21(4)):335-42 doi:10.1111/anec.12389.

    PMID: 27324981
  3. 3

    Socio-religious Prognosticators of Psychosocial Burden of Beta Thalassemia Major.

    Ul Hassan Rashid MA, Abbasi SS, Manzoor MM

    Journal of religion and health 2020; (59(6)):2866-2881 doi:10.1007/s10943-020-01069-6.

    PMID: 32696428
  4. 4

    An Unexpected Detection of the Rare 48,XXYY in the Prenatal Diagnosis of a Fetus with β-Thalassemia Major.

    Chen W, Ban S, Zhu Z, et al.

    Clinical laboratory 2024; (70(10)) doi:10.7754/Clin.Lab.2024.240517.

    PMID: 39382913
  5. 5

    Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.

    Kountouris P, Michailidou K, Christou S, et al.

    Haematologica 2021; (106(9)):2458-2468 doi:10.3324/haematol.2020.260224.

    PMID: 32732363
  6. 6

    Transition of Care for Patients with Thalassemia.

    Chandra J, Sahi PK

    Indian journal of pediatrics 2023; (90(12)):1227-1231 doi:10.1007/s12098-023-04595-9.

    PMID: 37133752
  7. 7

    Survival and causes of death in patients with alpha and beta-thalassemia in Northern Thailand.

    Tantiworawit A, Kamolsripat T, Piriyakhuntorn P, et al.

    Annals of medicine 2024; (56(1)):2338246 doi:10.1080/07853890.2024.2338246.

    PMID: 38604224
  8. 8

    Efficacy of combination chelation with deferasirox and deferiprone in children with beta-thalassemia major: an audit from a unit in the developing world.

    James V, Prakash A

    Clinical and experimental medicine 2025; (25(1)):299 doi:10.1007/s10238-025-01687-y.

    PMID: 40844717
  9. 9

    Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.

    Seyedifar M, Dorkoosh FA, Hamidieh AA, et al.

    International journal of hematology-oncology and stem cell research 2016; (10(4)):224-231.

    PMID: 27928477
  10. 10

    The Effect of Partnership Care Model on Mental Health of Patients with Thalassemia Major.

    Shamsi A, Amiri F, Ebadi A, Ghaderi M

    Depression research and treatment 2017; (2017()):3685402 doi:10.1155/2017/3685402.

    PMID: 28713591
  11. 11

    Impact of SCOPE Program on Health-Related Quality of Life and Health Status of Children With Thalassemia: A Quasi-Experimental Study.

    K K, A P, Sikandar BJ

    Journal of pediatric hematology/oncology nursing 2024; (41(3)):199-211 doi:10.1177/27527530231214542.

    PMID: 38646835

This guide provides educational information about Beta-thalassemia major and its treatments. Always consult your pediatric hematologist for personalized medical advice and treatment plans.

Get notified when new evidence is published on Beta-thalassemia major.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.